Views

CrossRef citations to date

Altmetric

Clinical Study

MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis

Nesrin BesbasDepartment of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey,

Mukaddes KalyoncuDepartment of Pediatric Nephrology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey,

Onur CilDepartment of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey,

Riza Koksal OzgulDepartment of Pediatric Metabolism, Hacettepe University Faculty of Medicine, Ankara, Turkey,

Aysin BakkalogluDepartment of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey,

Fatih OzaltinDepartment of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ;Nephrogenetics Laboratory, Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey, and ;Hacettepe University Center for Biobanking and Genomics, Ankara, TurkeyCorrespondence[email protected]

Figures & data

Table 1. Clinical and laboratory features of the patients with FSGS and SSNS at initial presentation and the disease course.

Download CSV Display Table

**Table 2. MCP1 2518 genotypic and allele frequencies of patients with FSGS, SSNS and healthy controls.**

Download CSV Display Table

Table 3. The genotypic frequencies in patients with and without chronic renal failure in FSGS group.

Download CSV Display Table

Table 4. Urinary CCL2/MCP-1 levels in patients with focal segmental glomerulosclerosis and SSNS, and control group.

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis

Table 1. Clinical and laboratory features of the patients with FSGS and SSNS at initial presentation and the disease course.

**Table 2. MCP1 2518 genotypic and allele frequencies of patients with FSGS, SSNS and healthy controls.**

Table 3. The genotypic frequencies in patients with and without chronic renal failure in FSGS group.

Table 4. Urinary CCL2/MCP-1 levels in patients with focal segmental glomerulosclerosis and SSNS, and control group.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis

Figures & data

Table 1. Clinical and laboratory features of the patients with FSGS and SSNS at initial presentation and the disease course.

Table 2. MCP1 2518 genotypic and allele frequencies of patients with FSGS, SSNS and healthy controls.

Table 3. The genotypic frequencies in patients with and without chronic renal failure in FSGS group.

Table 4. Urinary CCL2/MCP-1 levels in patients with focal segmental glomerulosclerosis and SSNS, and control group.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

**Table 2. MCP1 2518 genotypic and allele frequencies of patients with FSGS, SSNS and healthy controls.**